AUG 06, 2020 8:18 AM PDT

Gut Feeling: Spotting the Early Signs of Gastric Cancer

WRITTEN BY: Tara Fernandez

In a study published in Science Advances, scientists propose a new method for diagnosing gastric cancer, the third leading cause of death worldwide.

A gastric cancer diagnosis is usually linked to a poor clinical outcome. The reason? It’s notoriously difficult to diagnose this type of cancer in the early stages and by the time it is detected, the cancer may have already spread extensively. A diagnostic peritoneal lavage (a surgical diagnostic procedure to sample fluids in the abdominal cavity) is usually done in the case of suspected gastric cancer. The problem is that these fluid samples have very few if any, metastatic cancer cells during the early stages. Because of this, standard detection methods fall short.

The study led by Yuzhao Zhang from the Shenyang Institute of Automation in China describes a biomedical engineering breakthrough: a microfluidic chip that rapidly separates and characterizes floating gastric cancer cells. “Microfluidics technologies are used to precisely control, manipulate, and analyze fluids through deliberately designed microchannels,” the authors explain in the publication.

Gastric cancer develops when cells lining the stomach become malignant. Age, diet, smoking, and some infections can increase the risk of gastric cancer, with early symptoms including nausea, heartburn, and bloating.

Gastric cancer cells differ from normal peritoneal lavage cells in terms of their sizes and electrical characteristics. The microfluidic chip solved the problem of the low sensitivity in standard tests, by separating cancer cells from the normal abdominal fluid with a purity of up to 71 percent. Besides being sensitive, the new device was also rapid, separating cells in around 5 minutes.

This is the first time that scientists have been able to capture living gastric cancer cells from peritoneal lavages. “In the future, separated live cancer cells could be further cultured and used to study the mechanism of peritoneal metastasis,” the authors write.

 

Source: Science Advances


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 06, 2020
Clinical & Molecular DX
A Smart Tattoo That Could Save Your Life
OCT 06, 2020
A Smart Tattoo That Could Save Your Life
Color-changing tattoos, powered by nanotechnology, that sense imbalances in your biochemistry providing a visual signal ...
OCT 20, 2020
Clinical & Molecular DX
Non-coding RNA As A Barometer For Liver Health
OCT 20, 2020
Non-coding RNA As A Barometer For Liver Health
October is liver cancer awareness month — a month dedicated to educating people about the risk factors and prevent ...
NOV 03, 2020
Genetics & Genomics
One Eight Cancer Patients Also Carry Inherited Genetic Mutations
NOV 03, 2020
One Eight Cancer Patients Also Carry Inherited Genetic Mutations
Genetic sequencing technologies have rapidly advanced, reducing the time required to sequence the entire human genome fr ...
NOV 14, 2020
Cannabis Sciences
Half of CBD Users Test Positive for THC in Urine Tests
NOV 14, 2020
Half of CBD Users Test Positive for THC in Urine Tests
Despite the growing popularity of cannabidiol (CBD) products, there has been little research directly assessing whether ...
NOV 24, 2020
Cancer
Using Restfulness as a Metric for Measuring Sleep Quality and Cardiovascular Risk
NOV 24, 2020
Using Restfulness as a Metric for Measuring Sleep Quality and Cardiovascular Risk
Did you know sleeping is great? Apparently, getting a full eight hours every night can make you look fabulous and solve ...
NOV 30, 2020
Cancer
Developing Handheld Pulse Lasers to Destroy Cancer Tissue
NOV 30, 2020
Developing Handheld Pulse Lasers to Destroy Cancer Tissue
Many take modern surgeons and surgical methods for granted. In the grand scheme of things, it wasn’t too long ago ...
Loading Comments...